Cargando…
Acupuncture with different acupoint combinations for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial
BACKGROUND: Acupuncture is beneficial for controlling chemotherapy-induced nausea and vomiting (CINV). However, the effect of different acupoint combinations on controlling CINV remains unknown. This study aims to compare the effects of distal-proximal point association and local distribution point...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100267/ https://www.ncbi.nlm.nih.gov/pubmed/27821107 http://dx.doi.org/10.1186/s12906-016-1425-1 |
_version_ | 1782466107425161216 |
---|---|
author | Gao, Lili Chen, Bo Zhang, Qiwen Zhao, Tianyi Li, Bo Sha, Tao Zou, Jinxin Guo, Yongming Pan, Xingfang Guo, Yi |
author_facet | Gao, Lili Chen, Bo Zhang, Qiwen Zhao, Tianyi Li, Bo Sha, Tao Zou, Jinxin Guo, Yongming Pan, Xingfang Guo, Yi |
author_sort | Gao, Lili |
collection | PubMed |
description | BACKGROUND: Acupuncture is beneficial for controlling chemotherapy-induced nausea and vomiting (CINV). However, the effect of different acupoint combinations on controlling CINV remains unknown. This study aims to compare the effects of distal-proximal point association and local distribution point association on controlling CINV. METHODS/DESIGN: The study is a single-center, randomized controlled trial. A total of 240 participants will be randomly divided into four groups. The control group will receive standard antiemetic only, whereas three acupuncture groups will receive four electro-acupuncture treatments once a day with the standard antiemetic. Acupuncture group I and II will receive distal-proximal point association (“Neiguan (PC6) and Zhongwan (CV12)”, and “Zusanli (ST36) and CV12”, respectively); Acupuncture group III will receive local distribution point association (“Shangwan (CV13) and CV12”). The primary outcome measures are the frequency and distress of nausea and vomiting. The secondary outcome measures are the grade of constipation and diarrhea, electrogastrogram, quality of life, etc. Assessment is scheduled from the day before chemotherapy to the fifth day of chemotherapy. Follow-ups are performed from the sixth day to the twenty-first day of chemotherapy. DISCUSSION: Results of this trial will help in evaluating the efficacy and safety of electro-acupuncture with different acupoint combinations in the management of CINV. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02478047. |
format | Online Article Text |
id | pubmed-5100267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51002672016-11-08 Acupuncture with different acupoint combinations for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial Gao, Lili Chen, Bo Zhang, Qiwen Zhao, Tianyi Li, Bo Sha, Tao Zou, Jinxin Guo, Yongming Pan, Xingfang Guo, Yi BMC Complement Altern Med Study Protocol BACKGROUND: Acupuncture is beneficial for controlling chemotherapy-induced nausea and vomiting (CINV). However, the effect of different acupoint combinations on controlling CINV remains unknown. This study aims to compare the effects of distal-proximal point association and local distribution point association on controlling CINV. METHODS/DESIGN: The study is a single-center, randomized controlled trial. A total of 240 participants will be randomly divided into four groups. The control group will receive standard antiemetic only, whereas three acupuncture groups will receive four electro-acupuncture treatments once a day with the standard antiemetic. Acupuncture group I and II will receive distal-proximal point association (“Neiguan (PC6) and Zhongwan (CV12)”, and “Zusanli (ST36) and CV12”, respectively); Acupuncture group III will receive local distribution point association (“Shangwan (CV13) and CV12”). The primary outcome measures are the frequency and distress of nausea and vomiting. The secondary outcome measures are the grade of constipation and diarrhea, electrogastrogram, quality of life, etc. Assessment is scheduled from the day before chemotherapy to the fifth day of chemotherapy. Follow-ups are performed from the sixth day to the twenty-first day of chemotherapy. DISCUSSION: Results of this trial will help in evaluating the efficacy and safety of electro-acupuncture with different acupoint combinations in the management of CINV. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02478047. BioMed Central 2016-11-08 /pmc/articles/PMC5100267/ /pubmed/27821107 http://dx.doi.org/10.1186/s12906-016-1425-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Gao, Lili Chen, Bo Zhang, Qiwen Zhao, Tianyi Li, Bo Sha, Tao Zou, Jinxin Guo, Yongming Pan, Xingfang Guo, Yi Acupuncture with different acupoint combinations for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial |
title | Acupuncture with different acupoint combinations for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial |
title_full | Acupuncture with different acupoint combinations for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial |
title_fullStr | Acupuncture with different acupoint combinations for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial |
title_full_unstemmed | Acupuncture with different acupoint combinations for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial |
title_short | Acupuncture with different acupoint combinations for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial |
title_sort | acupuncture with different acupoint combinations for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100267/ https://www.ncbi.nlm.nih.gov/pubmed/27821107 http://dx.doi.org/10.1186/s12906-016-1425-1 |
work_keys_str_mv | AT gaolili acupuncturewithdifferentacupointcombinationsforchemotherapyinducednauseaandvomitingstudyprotocolforarandomizedcontrolledtrial AT chenbo acupuncturewithdifferentacupointcombinationsforchemotherapyinducednauseaandvomitingstudyprotocolforarandomizedcontrolledtrial AT zhangqiwen acupuncturewithdifferentacupointcombinationsforchemotherapyinducednauseaandvomitingstudyprotocolforarandomizedcontrolledtrial AT zhaotianyi acupuncturewithdifferentacupointcombinationsforchemotherapyinducednauseaandvomitingstudyprotocolforarandomizedcontrolledtrial AT libo acupuncturewithdifferentacupointcombinationsforchemotherapyinducednauseaandvomitingstudyprotocolforarandomizedcontrolledtrial AT shatao acupuncturewithdifferentacupointcombinationsforchemotherapyinducednauseaandvomitingstudyprotocolforarandomizedcontrolledtrial AT zoujinxin acupuncturewithdifferentacupointcombinationsforchemotherapyinducednauseaandvomitingstudyprotocolforarandomizedcontrolledtrial AT guoyongming acupuncturewithdifferentacupointcombinationsforchemotherapyinducednauseaandvomitingstudyprotocolforarandomizedcontrolledtrial AT panxingfang acupuncturewithdifferentacupointcombinationsforchemotherapyinducednauseaandvomitingstudyprotocolforarandomizedcontrolledtrial AT guoyi acupuncturewithdifferentacupointcombinationsforchemotherapyinducednauseaandvomitingstudyprotocolforarandomizedcontrolledtrial |